BioChain Institute, Inc.

Breaking New Ground in Gene Expression Analysis with Xenium Prime 5K At BioChain (www.biochain.com), we're thrilled to announce the Xenium Prime 5K Gene Expression Panel, a powerful new tool setting a new gene analysis standard. Imagine being able to analyze 5,000 genes in just five days – that's the efficiency, speed, and precision needed to accelerate breakthroughs. The Xenium Prime 5K is designed to unlock more profound insights into complex biological systems and help scientists gain a more comprehensive understanding of cellular function at an unprecedented scale. Whether you're focused on oncology, neuroscience, or immunology, this panel provides the power and scale to fast-track your research. Key Highlights of the Xenium Prime 5K: - Unmatched Speed: Full analysis of 5,000 genes in just five days. - High Precision & Reliability: Designed for consistent, accurate gene expression profiling. - Versatility Across Research Areas: Tailored for applications in cancer research, immunology, neuroscience, and more. This is more than just a panel – it's a leap forward in genomics, giving you a robust tool to unlock discoveries faster and more accurately. Let's push the boundaries of what's possible in gene expression analysis together! #BioChain #XeniumPrime5K #GeneExpression #Genomics #BiotechInnovation #LifeSciences #Research

 BioChain Institute at #SITC2024 📢 We’re excited to announce that BioChain Institute (www.biochain.com) will attend the upcoming Society for Immunotherapy of Cancer (SITC) 2024 conference in Houston, TX! Join us at Booth 428 for a closer look at how our innovative tools are empowering researchers in immuno-oncology. Don’t miss our poster presentations, where our team will be showcasing key findings: - November 8: Concordance assessment study of Xenium and Visium spatial transcriptomics assays using multiple carcinoma samples - Presented by Tong Lu - November 9:  Xenium in situ analysis and reproducibility study of multiple carcinomas for clinical studies- Presented by Vidyodhaya Sundaram, PhD, MBA We are looking forward to discussing the future of cancer immunotherapy with you! Learn more about our offerings in cancer research at www.biochain.com #SITC2024 #BioChain #CancerResearch #Immunotherapy #HoustonEvents

 BioChain Institute at #SITC2024 📢 We’re excited to announce that BioChain Institute (www.biochain.com) will attend the upcoming Society for Immunotherapy of Cancer (SITC) 2024 conference in Houston, TX! Join us at Booth 428 for a closer look at how our innovative tools are empowering researchers in immuno-oncology. Don’t miss our poster presentations, where our team will be showcasing key findings: - November 8: Concordance assessment study of Xenium and Visium spatial transcriptomics assays using multiple carcinoma samples - Presented by Tong Lu - November 9:  Xenium in situ analysis and reproducibility study of multiple carcinomas for clinical studies- Presented by Vidyodhaya Sundaram, PhD, MBA We are looking forward to discussing the future of cancer immunotherapy with you! Learn more about our offerings in cancer research at www.biochain.com #SITC2024 #BioChain #CancerResearch #Immunotherapy #HoustonEvents

 BioChain Institute at #SITC2024 📢 We’re excited to announce that BioChain Institute (www.biochain.com) will attend the upcoming Society for Immunotherapy of Cancer (SITC) 2024 conference in Houston, TX! Join us at Booth 428 for a closer look at how our innovative tools are empowering researchers in immuno-oncology. Don’t miss our poster presentations, where our team will be showcasing key findings: - November 8: Concordance assessment study of Xenium and Visium spatial transcriptomics assays using multiple carcinoma samples - Presented by Tong Lu - November 9:  Xenium in situ analysis and reproducibility study of multiple carcinomas for clinical studies- Presented by Vidyodhaya Sundaram, PhD, MBA We are looking forward to discussing the future of cancer immunotherapy with you! Learn more about our offerings in cancer research at www.biochain.com #SITC2024 #BioChain #CancerResearch #Immunotherapy #HoustonEvents

From bulk #RNAseq to 2D and 3D profiling in understanding #tumorevolution and #tumormicroenvironment, we have come so far!! Kudos to Li Ding and coworkers for their marvelous work on multiple tumor types using #multiomics approaches. Read more here 👉 https://lnkd.in/ghGyfqKC

🔬 Pancreatic Cancer, Lung Cancer, Stomach Cancer, and Carcinoid Cancer Awareness Month: Advancing Research for a Cure Together 🔬 Every step forward in cancer research relies on high-quality, reliable products that provide accurate and insightful data. In recognition of Cancer Awareness Month, BioChain (www.biochain.com) is highlighting a few of our cutting-edge products that help scientists worldwide move closer to breakthroughs: 📌 Tissue and Serum Samples: Our extensive tissue bank, including standard, diseased, and cancer-specific samples, offers unmatched resources for researchers studying cancer biomarkers, drug targets, and genetic mutations. 📌 NGS Library Preparation Kits: Designed for high precision, our next-generation sequencing kits simplify library preparation while ensuring accuracy and reproducibility, essential for understanding genetic variations and cancer progression. 📌 RNA & DNA Extraction Kits: Our easy-to-use kits streamline obtaining high-quality nucleic acids from various tissue types, critical for cancer genomics research. This month, we’re reminded of the importance of every person and every product in the battle against cancer. Let’s keep pushing the boundaries of what’s possible in cancer research. Together, we can drive impactful changes and bring hope to cancer patients. Learn more about how BioChain is supporting cancer research at www.biochain.com #CancerAwarenessMonth #CancerResearch #BioChain #InnovationInScience #Cancer

✨ Happy Diwali from BioChain! ✨ On this beautiful occasion of Diwali, we extend our warmest wishes to all our partners, customers, and team members celebrating the Festival of Lights. May this Diwali bring brightness, joy, and prosperity to your lives and homes. At BioChain, we're grateful for your continued trust and collaboration. As we celebrate the triumph of light over darkness, we are reminded of our shared commitment to advancing science, fostering innovation, and lighting the way to a healthier future. Wishing you a sparkling Diwali filled with happiness, health, and success. 🪔💫 #HappyDiwali #FestivalOfLights #BioChain #Diwali2024

🎃 Happy Halloween from BioChain! 👻 Wishing you a spooktacular day filled with fun, treats, and maybe a few tricks! 🧛♂️ While you enjoy the Halloween festivities, remember that at BioChain, we’re always working behind the scenes (no tricks here!) to provide the most reliable biosample solutions and cutting-edge biotech tools to support your research and innovation. Have a frightfully good time, and stay safe! 🧬 From all of us at BioChain – where science meets innovation. #HappyHalloween #BioChain #SpookyScience #Biosamples #Innovation

Enhance Your Research with IRB-Approved FFPE Tissue Blocks Garbage in, garbage out. Pharmaceutical professionals understand that sample quality is critical for good results. BioChain's FFPE tissue samples are rigorously prepared to ensure histological integrity and molecular stability, making them ideal for studies in genomics, oncology, and pathology. Blocks, curls and sections are available as well. Access our complete catalog of FFPE tissues to ensure reproducibility in your research: https://bit.ly/3BV30JN #FFPETissue #Histology #Reproducibility #Clinicalstud